Madrigal Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 311.3M | 321.1M | 287.3M | 212.8M | 137.3M | 103.3M | 62.2M | 14.6M |
| Cost of Goods Sold | 26.8M | 24.4M | 18.1M | 9.1M | 4.5M | 3.4M | 2.2M | 636K |
| Gross Profit | 284.5M | 296.6M | 269.1M | 203.7M | 132.7M | 99.9M | 60.0M | 14.0M |
| R&D Expenses | 108.7M | 116.3M | 174.0M | 54.1M | 44.2M | 25.6M | 68.7M | 71.1M |
| Operating Expenses | 377.2M | 356.2M | 383.1M | 250.9M | 212.0M | 166.9M | 176.3M | 176.5M |
| Operating Income | -92.7M | -59.6M | -114.0M | -47.2M | -79.3M | -67.0M | -116.3M | -162.5M |
| Other Income / Gains | -1.7M | 1.0M | -215K | 4.9M | 6.1M | 7.6M | 9.3M | 10.6M |
| Net Income | -94.4M | -58.6M | -114.2M | -42.3M | -73.2M | -59.4M | -107.0M | -152.0M |
| EPS (Diluted) | -3.25 | -2.57 | -5.08 | -1.90 | -3.32 | -2.71 | -4.92 | -7.10 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.914 | 0.924 | 0.937 | 0.957 | 0.967 | 0.967 | 0.965 | 0.957 |
| General And Administrative Expenses | 0 | 0 | 209.1M | 0 | 0 | 0 | 107.6M | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 268.5M | 240.0M | 209.1M | 196.9M | 167.9M | 141.2M | 107.6M | 105.4M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 404.1M | 380.7M | 401.2M | 260.0M | 216.6M | 170.3M | 178.5M | 177.2M |
| Interest Income | 8.2M | 9.5M | 10.3M | 8.2M | 9.4M | 11.1M | 13.0M | 14.2M |
| Interest Expense | 7.8M | 8.3M | 7.5M | 3.3M | 3.3M | 3.5M | 3.7M | 3.7M |
| Depreciation And Amortization | 386K | 392K | 358K | 377K | 379K | 363K | 298K | 267K |
| Ebitda | -86.2M | -49.9M | -106.4M | -38.6M | -69.6M | -55.6M | -103.0M | -148.0M |
| Ebitdaratio | -0.277 | -0.155 | -0.37 | -0.182 | -0.507 | -0.538 | -1.656 | -10.114 |
| Operating Income Ratio | -0.298 | -0.186 | -0.397 | -0.222 | -0.578 | -0.648 | -1.871 | -11.104 |
| Income Before Tax | -94.4M | -58.6M | -114.2M | -42.3M | -73.2M | -59.4M | -107.0M | -152.0M |
| Income Before Tax Ratio | -0.303 | -0.182 | -0.398 | -0.199 | -0.534 | -0.575 | -1.72 | -10.382 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.303 | -0.182 | -0.398 | -0.199 | -0.534 | -0.575 | -1.72 | -10.382 |
| Epsdiluted | -3.25 | -2.57 | -5.08 | -1.90 | -3.32 | -2.71 | -4.92 | -7.10 |
| Weighted Average Shs Out | 29.0M | 22.4M | 22.5M | 22.2M | 22.1M | 21.9M | 21.7M | 21.4M |
| Weighted Average Shs Out Dil | 29.0M | 22.4M | 22.5M | 22.2M | 22.1M | 21.9M | 21.7M | 21.4M |